Jeena Sikho Lifecare Limited share price
Jeena Sikho Lifecare Limited trades in ayurvedic products in India and internationally. It operates through Ayurvedic products/medicine, Ayurvedic healthcare services, and others segments. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and …Read more
- Market Cap₹ 4,828 Cr.
- Current Price₹ 388.30
- High / Low₹ 835 / 360
- Stock P/E20.5
- Book Value₹ 38
- Dividend Yield1.16 %
- ROCE54.5 %
- ROE61.30 %
- Face Value₹ 2.0
More figures (10)
- EPS (TTM)₹ 18.98
- Price / Book10.34
- OPM38.2 %
- Debt / Equity0.27
- Sales growth (4Y)57.7 %
- Profit growth (4Y)87.3 %
- Promoter holding72.5 %
- EV / EBITDA13.0
- Beta1.04
- All-time high₹ 2,499
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| JSLL | -21.88% | -32.83% | -42.87% | -42.95% | -47.55% | -16.22% | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Jeena Sikho Lifecare Limited is in the Medical Care Facilities industry (Healthcare), with a market value of ₹4,828 crore.
- It trades at 20.5 times its last 12 months' earnings and 10.3 times book value.
- Revenue grew 57.7% a year over the last 4 years, profit 87.3% a year.
- Return on equity was 61.3% and return on capital employed 54.5% in the latest year.
- Debt was 0.27 times shareholders' equity.
- The share price is 53.5% below its 52-week high and down 47.6% over one year.
- Promoters and insiders hold about 72.5%; institutions about 0.3%.
Pros
AI- Strong return on equity: 47.3% on average over the last 3 years.
- Latest quarter (Jun 2026): sales up 29% and profit up 29% from a year ago.
- Trades at 20.5 times earnings, below its 3-year median of 66.6.
- Borrowings are moderate at 0.27 times shareholders' equity.
- Institutional (FII + DII) holding has risen by 5.1 points over 10 quarters.
Cons
AI- Promoter holding has fallen by 2.27 points over 10 quarters, to 63.62%.
- Trades at 10.3 times its book value.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited trades in ayurvedic products in India and internationally. It operates through Ayurvedic products/medicine, Ayurvedic healthcare services, and others segments. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.
- Employees
- 4,299
- Head office
- Zirakpur
- NSE industry
- Consumer Services
Peer comparison
HealthcareConsumer ServicesMedical Care Facilities
Part ofNifty Microcap 250
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Jeena Sikho Lifecare | 388.30 | 20.5 | 4,828 | 1.16 | 66 | 28.51 | 224 | 28.76 | 54.5 | 61.3 | 10.34 | 38.2 | 0.27 | 72.48 | 801 | 57.7 |
| 2. | Apollo Hospitals Enterprise | 7,890.00 | 54.3 | 1,13,446 | 0.25 | 610 | 38.41 | 7,044 | 20.56 | 19.2 | 21.9 | 11.97 | 11.7 | 0.90 | 28.39 | 25,229 | 14.8 |
| 3. | Max Healthcare Institute | 846.00 | 56.7 | 82,342 | 0.23 | 323 | 4.87 | 2,366 | 16.70 | 12.6 | 14.3 | 7.66 | 22.8 | 0.32 | 28.20 | 8,225 | 22.4 |
| 4. | Aster DM Quality Care | 674.35 | 109.3 | 58,781 | 0.44 | 29 | -68.70 | 1,311 | 21.60 | 9.4 | 9.7 | 7.59 | 14.2 | 0.49 | 64.26 | 4,643 | 15.7 |
| 5. | Fortis Healthcare | 736.50 | 53.1 | 55,603 | 0.13 | 266 | 2.35 | 2,545 | 17.46 | 11.9 | 11.1 | 5.62 | 17.8 | 0.35 | 35.19 | 9,048 | 13.3 |
| 6. | Narayana Hrudayalaya | 1,719.40 | 42.5 | 34,921 | 0.26 | 207 | 5.37 | 2,684 | 78.05 | 11.4 | 19.7 | 7.70 | 15.5 | 1.29 | 67.23 | 7,896 | 20.5 |
| 7. | Global Health | 1,240.00 | 60.0 | 33,322 | 0.04 | 159 | -0.18 | 1,304 | 26.50 | 15.0 | 15.1 | 8.41 | 16.8 | 0.30 | 66.39 | 4,318 | 17.2 |
| 8. | Krishna Institute of Medical Sciences | 685.60 | 134.4 | 28,796 | 0.00 | 42 | -47.20 | 1,180 | 35.33 | 8.1 | 11.0 | 12.21 | 13.8 | 1.89 | 41.74 | 3,872 | 21.3 |
| 9. | Rainbow Children's Medicare | 1,248.90 | 44.4 | 12,634 | 0.28 | 63 | 16.23 | 470 | 33.17 | 16.8 | 17.9 | 7.69 | 23.7 | 0.54 | 52.29 | 1,703 | 13.1 |
| 10. | Park Medi World | 235.70 | 35.9 | 10,181 | 0.00 | 89 | — | 476 | — | 17.9 | 16.8 | 4.64 | 23.3 | 0.18 | 83.94 | 1,679 | 9.6 |
| Median: 17 Co. | 791.25 | 50.2 | 10,181 | 0.13 | 124 | 4.87 | 1,307 | 26.50 | 13.8 | 16.3 | 7.59 | 16.8 | 0.42 | 58.28 | 4,481 | 17.2 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own past sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
- UpdatesJeena Sikho Lifecare Limited has informed the Exchange regarding 'Non Applicability of Related Party Transaction for the Half Year ended September 30, 2024'.11-Nov-2024
- Related Party TransactionsJeena Sikho Lifecare Limited has informed the Exchange about the Non- Applicability of disclosure requirements on related Party Transactions under Regulation 23(9) of the SEBI (Li…08-Apr-2024
- Related Party TransactionsJeena Sikho Lifecare Limited has informed the Exchange about the Non- Applicability of disclosure requirements on related Party Transactions under Regulation 23(9) of the SEBI (Li…10-Oct-2023
- Related Party TransactionsJeena Sikho Lifecare Limited has informed the Exchange about the Non- Applicability of disclosure requirements on related Party Transactions under Regulation 23(9) of the SEBI (Li…11-Apr-2023
- General updatesJeena Sikho Lifecare Limited has informed the Exchange about Non-Applicability of disclosure of Related Party Transaction(s) under Regulation 23(9) of SEBI (Listing Obligation and…25-Nov-2022
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2022 | Mar 2026 | TTM |
|---|---|---|---|
| 147 | 801 | 851 | |
| YOY Sales Growth % | 446.80% | ||
| 129 | 452 | 489 | |
| Material Cost % | 10% | 11% | 12% |
| Employee Cost % | 23% | 19% | 19% |
| Other Expenses % | 54% | 26% | 27% |
| Operating Profit | 18 | 349 | 363 |
| OPM % | 12% | 44% | 43% |
| Other Income | 1 | 8 | 22 |
| Interest | 1 | 13 | 15 |
| Depreciation | 3 | 48 | 53 |
| Profit before tax | 15 | 297 | 316 |
| 26% | 25% | 25% | |
| Current tax | 4 | 80 | |
| Deferred tax | -0 | -4 | |
| 11 | 222 | 236 | |
| Minority share | -0 | -0 | |
| Profit to shareholders | 11 | 222 | |
| YOY Profit Growth % | 1,880.53% | ||
| EPS in Rs | 11.11 | 17.84 | 19.02 |
| Dividend Payout % | 6% |
Compounded Sales Growth
- TTM:
- 6%
Compounded Profit Growth
- TTM:
- 7%
Stock Price CAGR
- 3 Years:
- -16%
- 1 Year:
- -48%
Return on Equity
- 4 Years:
- 42%
- Last Year:
- 61%
| ₹ Cr | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| 469 | 801 | 851 | |
| YOY Sales Growth % | 70.84% | ||
| 353 | 452 | 489 | |
| Material Cost % | 7% | 11% | 12% |
| Employee Cost % | 21% | 19% | 19% |
| Other Expenses % | 45% | 26% | 27% |
| Operating Profit | 116 | 350 | 363 |
| OPM % | 25% | 44% | 43% |
| Other Income | 6 | 9 | 22 |
| Interest | 1 | 13 | 15 |
| Depreciation | 48 | 53 | |
| Profit before tax | 122 | 298 | 317 |
| 26% | 25% | 25% | |
| Current tax | 32 | 80 | |
| Deferred tax | -0 | -4 | |
| Net Profit | 222 | 237 | |
| EPS in Rs | 7.30 | 17.87 | 19.03 |
| Dividend Payout % | 6% |
Compounded Sales Growth
- TTM:
- 1%
Compounded Profit Growth
- TTM:
- 34%
Stock Price CAGR
- 3 Years:
- -16%
- 1 Year:
- -48%
Return on Equity
- 4 Years:
- 42%
- Last Year:
- 61%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 14 | 25 | 25 | 25 |
| Reserves | 112 | 161 | 231 | 442 |
| 1 | 58 | 117 | 127 | |
| Long term borrowings | 1 | 0 | 0 | 0 |
| Short term borrowings | 0 | 0 | 10 | 0 |
| 24 | 29 | 46 | 80 | |
| Trade payables | 6 | 4 | 16 | 23 |
| Minority interest | -0 | |||
| Current liabilities | 25 | 36 | 73 | 105 |
| Total Liabilities | 151 | 272 | 419 | 674 |
| 67 | 127 | 226 | 235 | |
| Gross block | 78 | 138 | 265 | 324 |
| Accumulated depreciation | 11 | 10 | 38 | 89 |
| Goodwill & intangibles | 0 | 0 | 63 | 62 |
| CWIP | 7 | 3 | 12 | 3 |
| 77 | 141 | 181 | 437 | |
| Inventories | 4 | 7 | 12 | 20 |
| Trade receivables | 22 | 34 | 85 | 70 |
| Cash & equivalents | 32 | 25 | 23 | 16 |
| Current assets | 77 | 136 | 135 | 341 |
| Total Assets | 151 | 272 | 419 | 674 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 17 | 37 | 85 | 254 | |
| Profit for the year | 34 | 69 | 80 | 222 |
| Working capital changes | -21 | -32 | -31 | -31 |
| Direct taxes paid | -8 | -25 | -33 | -74 |
| -57 | -18 | -64 | -202 | |
| Fixed assets purchased | -38 | -16 | -42 | -34 |
| Fixed assets sold | 8 | 2 | 3 | 1 |
| Investments purchased | -26 | -17 | -14 | -196 |
| Investments sold | 5 | 56 | 25 | |
| 48 | -3 | -22 | -59 | |
| Proceeds from borrowings | 10 | 0 | ||
| Repayment of borrowings | -0 | -10 | ||
| Interest paid | -1 | -0 | -9 | -13 |
| Dividends paid | -3 | -10 | -14 | |
| Net Cash Flow | 8 | 15 | -2 | -7 |
| Free Cash Flow | -21 | 21 | 42 | 220 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | 26.8% | 44.4% | 36.2% | 61.3% |
| Operating margin | 12.3% | 22.7% | 27.1% | 24.0% | 43.6% |
| Net margin | 7.6% | 16.5% | 21.3% | 17.0% | 27.7% |
Balance-sheet ratios
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE | 35.7% | 39.7% | 34.1% | 54.5% |
| Debt / equity | 0.01 | 0.31 | 0.46 | 0.27 |
| Current ratio | 3.15 | 3.83 | 1.84 | 3.25 |
| Debtor days | 40 | 38 | 66 | 32 |
| Inventory days | 69 | 84 | 78 | 81 |
| Days payable | 102 | 52 | 106 | 92 |
| Cash conversion cycle | 7 | 70 | 38 | 21 |
| Working capital days | 95 | 113 | 48 | 108 |
ROE = profit for shareholders ÷ average net worth (paid-up capital + reserves, from each year's March results filed with NSE). Interest coverage = (profit before tax + interest) ÷ interest. ROCE = EBIT ÷ (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; working capital days = (current assets − current liabilities) ÷ sales × 365. Balance-sheet ratios are shown for the years whose full balance sheet is available (Yahoo Finance and NSE filings from FY2025).
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 63.62%
- FIIs 4.78%
- DIIs 0.36%
- Public 31.23%
| % | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 65.89% | 66.20% | 67.91% | 67.91% | 65.84% | 63.53% | 63.61% | 63.62% | 63.62% | 63.62% |
| 2.00% | 0.26% | 4.05% | 5.95% | 6.59% | 6.31% | 6.17% | 4.78% | |||
| Foreign portfolio investors (Cat. I) | 2.00% | 0.26% | 3.88% | 5.90% | 6.48% | 6.22% | 6.04% | 4.76% | ||
| Foreign portfolio investors (Cat. II) | 0.17% | 0.05% | 0.11% | 0.09% | 0.13% | 0.02% | ||||
| 0.04% | 0.07% | 0.17% | 0.15% | 0.11% | 0.46% | 0.36% | ||||
| Mutual funds | 0.11% | 0.10% | ||||||||
| Alternative investment funds | 0.04% | 0.07% | 0.17% | 0.15% | 0.11% | 0.35% | 0.26% | |||
| 34.11% | 33.80% | 30.05% | 31.83% | 30.04% | 30.34% | 29.65% | 29.96% | 29.76% | 31.23% | |
| Retail (up to ₹2 lakh) | 9.41% | 8.94% | 9.10% | 8.91% | 9.23% | 10.39% | 11.14% | 11.44% | 12.36% | 15.11% |
| HNIs (above ₹2 lakh) | 6.80% | 6.34% | 5.31% | 8.43% | 7.49% | 6.28% | 6.17% | 6.76% | 6.02% | 5.91% |
| NRIs | 0.40% | 0.41% | 0.39% | 0.64% | 0.46% | 0.64% | 0.83% | 0.94% | 1.07% | 1.10% |
| Bodies corporate | 14.08% | 15.53% | 13.75% | 12.69% | 11.33% | 11.53% | 10.14% | 9.24% | 8.66% | 7.25% |
| No. of Shareholders | 834 | 663 | 815 | 2,721 | 3,423 | 5,967 | 16,362 | 22,181 | 25,905 | 43,413 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding Jeena Sikho Lifecare
No single fund or institution holds more than 1%.
As named in the shareholding pattern for Jun 2026 filed with NSE; mutual funds together hold 0.10% of the company. Shareholders below 1% are not named in the filing.
Documents
Announcements
- ESOP/ESOS/ESPSJeena Sikho Lifecare Limited has informed the Exchange regarding Allotment of 23374 Shares.10-Oct-2026
- Allotment of SecuritiesJeena Sikho Lifecare Limited has informed the Exchange regarding allotment of 23374 Equity shares under the Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024 ("ESOS 2…10-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Jeena Sikho Lifecare Limited has informed the Exchange about Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201807-Oct-2026
- Product launchJeena Sikho Lifecare Limited has informed the Exchange about Launch of New Products.05-Oct-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Receipt of NABH Accreditation for Raipur Hospital.01-Oct-2026
- Shareholders meetingJeena Sikho Lifecare Limited has submitted the Exchange a copy Srutinizers report of 9th Annual General Meeting held on September 28, 2026. Further, the company has informed the E…30-Sep-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and…30-Sep-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and…29-Sep-2026
- Shareholders meetingJeena Sikho Lifecare Limited has informed the Exchange regarding Proceedings of 9th Annual General Meeting held on September 28, 202628-Sep-2026
- Trading WindowJeena Sikho Lifecare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201525-Sep-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Intimation of In-Principle Approval Received from BSE Limited for Listing of Up to a Maximum Of 6,50,000 Equity Shares…23-Sep-2026
- Product launchJeena Sikho Lifecare Limited has informed the Exchange about launch of new Products.21-Sep-2026
Annual reports
Credit ratings
None filed recently.
Concalls & investor meets
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Schedule of meet22-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Intimation of Analyst / Investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements…29-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Analyst / Investor meet scheduled to be held on 31st August, 2026.25-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Submission of Transcript of Earnings Conference Call for the quarter ended June 30, 2026.14-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Submission of audio recording of Earnings Conference Call Q1 FY 2026-2710-Aug-2026
- Investor PresentationJeena Sikho Lifecare Limited has informed the Exchange about Investor Presentation09-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Intimation of Earnings Conference Call for Investors and Analysts for Q1 FY26-27.04-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Intimation of Analyst / Investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements…17-Jun-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Intimation of Investor/ Analysts Meet/Conference under Regulation 30 of Securities and Exchange Board of India (Listin…09-Jun-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Submission of Transcript of Earnings Conference Call for the quarter and financial year ended 31st March, 202608-Jun-2026
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 21 Sep 2026
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
In the news
From the company (NSE)
- ESOP/ESOS/ESPSJeena Sikho Lifecare Limited has informed the Exchange regarding Allotment of 23374 Shares.NSE filing · 10-Oct-2026
- Allotment of SecuritiesJeena Sikho Lifecare Limited has informed the Exchange regarding allotment of 23374 Equity shares under the Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024 ("ESOS 2…NSE filing · 10-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Jeena Sikho Lifecare Limited has informed the Exchange about Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018NSE filing · 07-Oct-2026
- Product launchJeena Sikho Lifecare Limited has informed the Exchange about Launch of New Products.NSE filing · 05-Oct-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Receipt of NABH Accreditation for Raipur Hospital.NSE filing · 01-Oct-2026
- Shareholders meetingJeena Sikho Lifecare Limited has submitted the Exchange a copy Srutinizers report of 9th Annual General Meeting held on September 28, 2026. Further, the company has informed the E…NSE filing · 30-Sep-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and…NSE filing · 30-Sep-2026
- General UpdatesJeena Sikho Lifecare Limited has informed the Exchange about Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and…NSE filing · 29-Sep-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about Jeena Sikho Lifecare Limited
What is the share price of Jeena Sikho Lifecare Limited today?
What is the market cap of Jeena Sikho Lifecare Limited?
What is the P/E ratio of Jeena Sikho Lifecare Limited?
Is Jeena Sikho Lifecare Limited a good investment?
How can I buy Jeena Sikho Lifecare Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.